ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
5.88
+0.23 (4.07%)
Nov 1, 2024, 4:00 PM EDT - Market closed
ReShape Lifesciences Employees
ReShape Lifesciences had 29 employees as of December 31, 2023. The number of employees decreased by 11 or -27.50% compared to the previous year.
Employees
29
Change (1Y)
-11
Growth (1Y)
-27.50%
Revenue / Employee
$277,448
Profits / Employee
-$311,034
Market Cap
2.98M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Venus Concept | 304 |
Molecular Templates | 62 |
Windtree Therapeutics | 20 |
Heart Test Laboratories | 15 |
Bluejay Diagnostics | 10 |
Phio Pharmaceuticals | 9 |
Qualigen Therapeutics | 4 |
Protagenic Therapeutics | 3 |
RSLS News
- 6 weeks ago - ReShape Lifesciences Announces 1-for-58 Reverse Stock Split - GlobeNewsWire
- 2 months ago - ReShape Lifesciences Inc. (RSLS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update - GlobeNewsWire
- 3 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of Shareholders - GlobeNewsWire
- 3 months ago - RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLS - Business Wire
- 4 months ago - Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND” - GlobeNewsWire
- 4 months ago - ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys - GlobeNewsWire
- 6 months ago - ReShape Lifesciences, Inc. (RSLS) Q1 2024 Earnings Call Transcript - Seeking Alpha